EULAR: European League Against Rheumatism

Conference Coverage

TNF inhibitors cut odds of VTE in RA patients

Rather than increase risk for venous thromboembolism events, TNF inhibitors cut risk by nearly half, and other newer biologics lowered risk by...

Pages